Place the orally disintegrating tablet on the tongue. It will rapidly dissolve and can be swallowed with or without water. Take once daily in the evening for asthma or allergic rhinitis, or at least 2 hours before exercise for EIB.

Montelukast selectively binds to and inhibits the cysteinyl leukotriene type 1 (CysLT1) receptor. Leukotrienes are potent inflammatory mediators that are released from various cells, including mast cells and eosinophils, and contribute to the pathophysiology of asthma and allergic rhinitis.

• •Hypersensitivity to Montelukast or any component of the formulation

Store below 30°C in a dry place, protected from light and moisture. Keep out of reach of children.

In cases of overdose, common adverse reactions include abdominal pain, somnolence, thirst, headache, vomiting, and psychomotor hyperactivity. Treatment is symptomatic and supportive.

Pregnancy Category B. Use during pregnancy only if clearly needed. Montelukast is excreted in breast milk; caution should be exercised when administered to a nursing mother.